The Care Quality Commission has raised a number of concerns related to the prescribing of cannabis-based products for medicinal use in the UK, as the latest data reveals further increases in private prescriptions. Earlier this month the independent regulator which is responsible for overseeing health and [...]
An international survey of people living with eating disorders has found that cannabis and psychedelics, such as ‘magic mushrooms’ or LSD, were best rated as alleviating symptoms by respondents who self-medicated with the non-prescribed drugs. The worst-rated drugs were alcohol, tobacco, nicotine and cocaine. Meanwhile, prescribed [...]
The European medical cannabis sector is experiencing unprecedented growth, driven by progressive legislation, expanding patient access, and a maturing supply chain, according to a new report. Findings from The European Cannabis Report: 10th Edition, published today (Tuesday 29 July), reflect a decade of immense change across European [...]
Current methods used by police to detect drug driving are not based on science, say the authors of a new paper calling for an overhaul of cannabis impairment testing. As cannabis becomes legal in a growing number of US states, public safety experts have raised concerns [...]
In a special edition of the Business of Cannabis Podcast, we go from ‘anecdote to evidence’ with Dr Anne Katrin Schlag, Head of Research and Interim CEO at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf. Together, they explore how the UK can move [...]
Over four years after its slated launch, the NHS Cannabis Patient Registry is set to publish its first data. The years of obfuscation and delay prompted a Freedom of Information request by Business of Cannabis, which has established that the NHS will publish data from its ‘registry’ by the ‘end [...]
By Dr Sue Clenton, Medical Director, Rupa Shah, Chief Legal and Compliance Officer, and Graham Woodward, Chief Operations Officer, Releaf In a healthcare landscape as tightly regulated as the UK’s medical cannabis sector, building a clinical team isn’t just operational work, it’s mission-critical. With the field [...]
A new clinical trial will investigate the potential of cannabis-based treatment to improve quality of care for hospice eligible patients with dementia. The University of Maryland School of Medicine (UMSOM) Palliative Medicine Program has launched a new clinical trial funded by the National Institute on Aging [...]
It’s natural to have questions when considering a new medication, and for many exploring medical cannabis, a common query is about its effects, particularly the feeling often described as a “high.” While cannabis has a long history of medicinal use globally and became legal for medical [...]
Over the past eight months, Business of Cannabis, Cannabis Health, leafie and CannaReporter have conducted a wide-ranging investigation into Dr Green Digital Key — a high-profile blockchain project positioning itself as a game-changer in global cannabis access. Backed and vocally promoted by a man who styles [...]
Research from two separate studies has highlighted how promotional packaging and social media content can make cannabis-infused products more appealing to teens, prompting calls for more effective regulations. Bright colours, fruit imagery, and labels like “locally made” or “vegan” when used on packaging for cannabis edibles [...]
Patients have called for Switzerland’s new cannabis laws to address ‘unsatisfactory’ medical access ahead of an upcoming consultation on the draft legislation. As legislators look to make further reforms to Switzerland’s cannabis laws, campaigners are urging them to consider the daily realities of those who rely [...]
In the first controlled clinical trial of CBD in boys with autism, two-thirds of participants showed behavioural improvements with treatment, but there was also a significant placebo effect. Researchers at the Center for Medicinal Cannabis Research at University of California San Diego School of Medicine have [...]
The UK’s Food Standards Agency (FSA) has announced some significant updates to its multi-year CBD Novel Foods approvals process, finally offering hundreds of long-suffering businesses some light at the end of the tunnel. Following suggestions from the FSA late last year that it planned to ‘clearly communicate [...]
A brutally honest call-in to the UK medical cannabis patient community, about ego, division, and why we’re our own worst enemy.
The post This Isn’t a Movement, It’s a Mess first appeared on PatientsCann UK.
Words by Dr Sue Clenton, Medical Director, Releaf Over the past year, we’ve seen medical cannabis move from the margins toward the mainstream — not through media headlines or marketing campaigns, but in clinics, in consultations, and in the steady accumulation of patient outcomes. At Releaf, [...]
Patients in Australia living with endometriosis say cannabis is more-effective for managing their symptoms, and has fewer side-effects than pharmaceutical medications, a new survey finds. According to new survey data published in the journal Reproduction & Fertility, the majority of patients using cannabis to manage symptoms of endometriosis, find [...]
Ukraine has officially issued its first ever permit for medical cannabis to be imported into the country, bringing patients one step closer to receiving treatment. It represents the latest development in Ukraine’s nascent but rapidly evolving medical cannabis programme, after the country officially enshrined it into law [...]
Ahead of European Cannabis Week, Grow Group’s Managing Director, Pierre van Weperen, talks to Cannabis Health about the current state of play, and the future of cannabis-based medicine in the UK. More than 6.4 million people in the UK are currently waiting for treatment on the [...]
A national class action has been brought against Aurora Cannabis in Canada, alleging that the company ‘negligently’ failed to warn consumers about the risk of developing Cannabinoid Hyperemesis Syndrome (CHS). On May 14, 2025, the Ontario Superior Court of Justice certified a national class action alleging [...]
A profound change is quietly occurring across the UK, writes James Smith, medical cannabis patient and co-founder of 4C Labs, following a recent experience using cannabis-based medicines to recover from major hip surgery on the NHS. Disclaimer: I am not a doctor or a scientist, this [...]
A new UK study highlights how medical cannabis may improve quality of life for people living with obsessive compulsive disorder (OCD). Researchers at Drug Science analysed data from what they believe to be the largest sample of OCD patients receiving cannabis-based medicines on prescription. OCD is estimated [...]
Two cannabis-derived compounds have shown remarkable effectiveness against fungal pathogens in laboratory tests, according to new research. In a study published in The Journal of Neglected Tropical Diseases (PLOS NTDs), researchers discovered that Cannabidiol (CBD) and Cannabidivarin (CBDV) killed harmful Cryptococcus neoformans – a WHO-listed priority fungal pathogen. [...]
The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products. Seven years since the first unlicensed cannabis-based medicinal products (CBPMs) were prescribed in the UK, the [...]
The Czech Republic’s Chamber of Deputies has approved a landmark amendment which, if passed through the Senate, will legalise home cultivation of up to three plants, home possession of up to 100g of cannabis per person, and public possession of up to 25g per person. Its [...]
Cannabis use among older adults in the US has reached a new high, with 7% of adults aged 65 and over who report using it in the past month. This is according to an analysis led by researchers with the Center for Drug Use and HIV/HCV [...]
Every year, Men’s Health Week serves as a crucial reminder to pause and reflect on the health challenges that many men face – but often don’t talk about. It’s a time to raise awareness of how gender, culture and environment can affect our health, and to [...]
Words by Dr Sue Clenton, Medical Director, Releaf If we are serious about the future of medical cannabis in the UK, we must be equally serious about its clinical foundations. That means investing not just in science or access, but in a new generation of [...]
Chronic pain affects millions of people in the UK. As the conversation around medical cannabis evolves, many patients and GPs are beginning to explore whether medical cannabis could offer an alternative. In this instalment of our medical cannabis education series, Dr Elisabeth Philipps is joined by [...]
The UK government has rejected a petition calling for patients with a prescription for cannabis-based medicines to be allowed to grow their own plants at home. Around 13,000 people signed a petition calling for ‘Grow Your Own’ laws to allow patients with a prescription for cannabis-based [...]
The Medical Cannabis Clinicians Society (MCCS) has published its first comprehensive guidance specifically for pharmacy professionals involved in the dispensing of cannabis-based medicinal products (CBPMs) in the UK. Pharmacists play a vital role in the dispensing of CBPMs and have a responsibility to ensure these medications [...]
New research sheds light on the impact of cannabis legalisation on prescription drug claims following their implementation in the US. Approval of recreational and medical cannabis laws in most US states has allowed individuals to legally obtain cannabis to treat certain medical ailments that had typically [...]
The first academic research on Switzerland’s landmark adult-use pilot, has reported a decline in problematic consumption, particularly among those who used other drugs in addition to cannabis. Europe’s first adult-use cannabis pilot programme, the Weed Care study, launched in Basel, Switzerland, in January 2023, to examine [...]
Denmark has officially passed legislation which will solidify its long-running medical cannabis pilot programme as a permanent fixture of its national healthcare system in what has been described as a ‘victory for patients’. First announced in November 2024, the medical cannabis bill (L135) has undergone an [...]
If you’ve been prescribed medical cannabis flower, it’s recommended you administer your medicine with a medical-grade vaporiser. Smoking medical cannabis is illegal, but it also exposes you to harmful toxins. Vaporising heats the cannabis flower without combustion, preserving its active compounds while avoiding the harmful byproducts [...]
Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education. A report published by Volteface in 2022 found that in the UK, while around 40,000 clinicians are eligible to prescribe medical cannabis, only [...]
The ‘remarkable’ mother and campaigner, who played a pivotal role in the legalisation of medical cannabis in the UK, Hannah Deacon, has died at the age of 45. In a statement on her website, Hannah’s loved ones said they were ‘heartbroken’ to share the news of [...]
New analysis from the UK has found that cannabis-based medicines are associated with improvements in symptoms and overall quality of life in patients with treatment-resistant epilepsy. Researchers say the study, which analysed data from the UK Medical Cannabis Registry (UKMCR), shows the ‘promising potential’ of cannabis-based [...]
After a six-year battle on behalf of campaigners, Romania’s Health Committee has rejected a bill which would broaden access to medical cannabis products on prescription. Following what has been described as “six years of silence”, in February, Romania’s Health Committee of the [...]
Dying Matters Awareness Week encourages open conversations about end-of-life care, helping to break the stigma around death and dying. This year’s discussions feel particularly timely, as the UK’s Terminally Ill Adults (End of Life) Bill moves forward[1]. If passed, the bill could change the future of [...]
New research reveals that the use of cannabidiol (CBD) cannabis extract can lead to meaningful benefits and improve behaviour in children and teenagers with autism spectrum disorder (ASD). ASD affects approximately one in 100 children around the world and symptoms can include difficulty interpreting language, difficulty [...]
A new pilot study has examined how medically supervised cannabis use in a residential recovery home may support people in treatment for substance use challenges. The study, recently published in the Journal of Studies on Alcohol and Drugs, was conducted by researchers from UBC Okanagan and [...]
A cannabis executive is calling for law enforcement agencies to be better educated on medical cannabis, after a court ruled UK border force officers wrongfully seized his prescription. The managing director of the Canndr medical cannabis platform has spoken publicly for the first time after winning [...]
The largest meta-analysis of scientific data on medical cannabis’ viability in cancer treatment to date has been published, finding overwhelmingly positive consensus for its therapeutic potential. In a comprehensive review drawing on a dataset of over 10,000 peer-reviewed publications and nearly 40,000 associated data points, the Whole Health Oncology [...]
Patients prescribed medical cannabis in Australia maintained improvements in overall health-related quality of life (HRQL), fatigue, and sleep disturbance across a one-year period, according to new research. The study, published in the journal PLOS One by researchers at the University of Sydney, also found that anxiety, [...]
As the UK’s fastest-growing medical cannabis clinic, Releaf is committed to not only addressing an unmet healthcare need but doing so in a safe and clinically responsible manner. This is even more important with the medical cannabis industry coming under closer scrutiny from regulators such as [...]
The U.S. cannabis brand STIIIZY is expanding its footprint with the opening of its newest retail location in Hawthorne, CA on April 12th. As the brand’s 44th dispensary, the new storefront is located at 12831 Crenshaw Blvd, Hawthorne, CA. Perfectly located on Crenshaw Blvd [...]
The number of pregnant women using cannabis in the US has more than tripled over the last two decades, with researchers calling for further studies to inform intervention approaches. Cannabis use has been increasing during pregnancy, according to researchers at Columbia University Mailman School of Public [...]
Scientists at the University of South Australia say they have developed an innovative solution to improve the effectiveness of cannabidiol to treat epilepsy, multiple sclerosis and other neurodegenerative diseases. Cannabidiol (CBD), the non-psychoactive compound found in the cannabis plant, is widely prescribed for its analgesic, anti-inflammatory [...]
France’s four-year campaign to launch a fully regulated generalised medical cannabis framework is finally being realised. Just weeks ago thousands of participants in Frances’ medical cannabis ‘experiment’, launched in 2021, were preparing to wean themselves off the treatment and had been instructed by the government to [...]
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
